Cytomed Therapeutics revenue was $0.00 for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2024) ending on Jun 30, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, GDTC annual revenue was $0.0, with N/A growth year-over-year.
GDTC revenue history
Current Revenue
$0.0
Current Earnings
-$2.3M
Current Profit Margin
0%
Be the first to know when GDTC announces revenue.
GDTC Revenue History By Year
GDTC Yearly Revenue
GDTC Revenue
GDTC Change
GDTC Revenue Growth
2023-12-31
$0.00
N/A
N/A
2022-12-31
$0.00
N/A
N/A
2021-12-31
$0.00
N/A
N/A
2020-12-31
$0.00
N/A
N/A
1 of 1
Cytomed Therapeutics Revenue FAQ
What was GDTC's revenue last quarter?
Cytomed Therapeutics (NASDAQ: GDTC) reported Q2 2024 revenue of N/A up N/A year over year. In the same quarter last year, Cytomed Therapeutics's revenue was N/A.
What was Cytomed Therapeutics's revenue in 2023?
Cytomed Therapeutics's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
How much does Cytomed Therapeutics make in a day?
Based on Cytomed Therapeutics annual revenue for the past three years, GDTC makes an average of $0.00 per day.
What was Cytomed Therapeutics's annual revenue growth in the past year?
As of Q1 2025, Cytomed Therapeutics's revenue has grown null year over year. Cytomed Therapeutics's revenue in the past year totaled $0.00.
How much does Cytomed Therapeutics make in a year?
Cytomed Therapeutics's revenue by year for the past three years is:
Cytomed Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
Cytomed Therapeutics's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
Cytomed Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.